MDT
89.97
+2.2%↑
MDT
89.97
+2.2%↑
MDT
89.97
+2.2%↑
MDT
89.97
+2.2%↑
MDT
89.97
+2.2%↑
24h
Current
Min
7
Max
7.19
Recommendations | Neutral |
---|---|
12 Months Forecast | +36.01 upside |
Next Earnings | 27 Mar 2025 |
---|
By Acuity
34%
66%
92 / 393 Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
N/A / 8.08 Support & Resistance
Past performance is not a reliable indicator of future results.
16 Jan 2025, 16:17 UTC
Atara Shares Sink After FDA Stalls Cancer Treatment
DJ
Read
16 Jan 2025, 14:31 UTC
FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 9.67 USD 36.01%
High 17 USD
Low 5 USD
Based on 4 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.
By TipRanks
Neutral
4 ratings
1
Buy
3
Hold
0
Sell
Based on 4 analysts giving stock ratings to Atara Biotherapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
$